Seroprevalence of SARSCoV-2–specific antibodies, Faroe Islands

Maria Skaalum Petersen; Marin Strøm; Debes Hammershaimb Christiansen; Jógvan Páll Fjallsbak; Eina Hansen Eliasen; Malan Johansen; Anna Sofía Veyhe; Marnar Fríðheim Kristiansen; Shahin Gaini; Lars Fodgaard Møller; Bjarni Steig; Pál Weihe

doi:10.3201/eid2611.202736

Seroprevalence of SARSCoV-2–specific antibodies, Faroe Islands

Maria Skaalum Petersen^*
, Marin Strøm
, Debes Hammershaimb Christiansen
, Jógvan Páll Fjallsbak
, Eina Hansen Eliasen
, Malan Johansen
, Anna Sofía Veyhe
, Marnar Fríðheim Kristiansen
, Shahin Gaini
, Lars Fodgaard Møller
, Bjarni Steig
, Pál Weihe

^*Corresponding author for this work

KI, OUH, Research unit of Infectious Diseases (Odense)

University of the Faroe Islands
Faroese Food and Veterinary Authority
Faroese Hospital System
National Hospital of the Faroe Islands
Ministry of Health Affairs
Chief Medical Officer Office

Research output: Contribution to journal › Journal article › Research › peer-review

78 Downloads (Pure)

Abstract

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Original language	English
Journal	Emerging Infectious Diseases
Volume	26
Issue number	11
Pages (from-to)	2760-2762
ISSN	1080-6059
DOIs	https://doi.org/10.3201/eid2611.202736
Publication status	Published - Nov 2020

Funding

The project is funded by the Lundbeck Foundation (R349-2020-805).

Documents & Links

10.3201/eid2611.202736Licence: CC BY

Open Access VersionFinal published version, 323 KBLicence: CC BY

SDU Link

Check access to the material in SDU Library's search engine

Cite this

@article{fc164aeb560144a3973d9419d12ced29,

title = "Seroprevalence of SARSCoV-2–specific antibodies, Faroe Islands",

abstract = "We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6\%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7\% prevalence. Our findings will help us evaluate our public health response.",

author = "Petersen, \{Maria Skaalum\} and Marin Str{\o}m and Christiansen, \{Debes Hammershaimb\} and Fjallsbak, \{J{\'o}gvan P{\'a}ll\} and Eliasen, \{Eina Hansen\} and Malan Johansen and Veyhe, \{Anna Sof{\'i}a\} and Kristiansen, \{Marnar Fr{\'i}{\dh}heim\} and Shahin Gaini and M{\o}ller, \{Lars Fodgaard\} and Bjarni Steig and P{\'a}l Weihe",

year = "2020",

month = nov,

doi = "10.3201/eid2611.202736",

language = "English",

volume = "26",

pages = "2760--2762",

journal = "Emerging Infectious Diseases",

issn = "1080-6059",

publisher = "CDC Centers for Disease Control and Prevention",

number = "11",

}

TY - JOUR

T1 - Seroprevalence of SARSCoV-2–specific antibodies, Faroe Islands

AU - Petersen, Maria Skaalum

AU - Strøm, Marin

AU - Christiansen, Debes Hammershaimb

AU - Fjallsbak, Jógvan Páll

AU - Eliasen, Eina Hansen

AU - Johansen, Malan

AU - Veyhe, Anna Sofía

AU - Kristiansen, Marnar Fríðheim

AU - Gaini, Shahin

AU - Møller, Lars Fodgaard

AU - Steig, Bjarni

AU - Weihe, Pál

PY - 2020/11

Y1 - 2020/11

N2 - We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

AB - We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

U2 - 10.3201/eid2611.202736

DO - 10.3201/eid2611.202736

M3 - Journal article

C2 - 32726200

AN - SCOPUS:85093897197

SN - 1080-6059

VL - 26

SP - 2760

EP - 2762

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 11

ER -

Seroprevalence of SARSCoV-2–specific antibodies, Faroe Islands

Abstract

Funding

Documents & Links

SDU Link

Fingerprint

Cite this